Audentes Therapeutics (BOLD)

26.91 -0.18 (0.66%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/19 *Est.)

Latest Headlines

Form 8-K Audentes Therapeutics, For: Oct 05 October 9, 2019 6:01 AM - SEC Filing Audentes Therapeutics (BOLD) Announces Positive AT132 Trial Data October 7, 2019 7:20 AM - StreetInsider Mizuho Securities Reiterates Buy Rating on Audentes Therapeutics (BOLD) Following Updated Data October 7, 2019 7:19 AM - StreetInsider Audentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked Myotubular Myopathy (XLMTM), at the 24th International Annual Congress of th October 5, 2019 7:01 AM - BizWire Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 4, 2019 6:00 PM - BizWire Baird Starts Audentes Therapeutics (BOLD) at Underperform October 2, 2019 4:27 PM - StreetInsider Audentes Therapeutics to Participate in Upcoming Investor Conferences October 1, 2019 8:00 AM - BizWire Audentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including New Data From ASPIRO, the Clinical Trial Evaluating AT132 in Patients With X- September 30, 2019 8:00 AM - BizWire Form 4 Audentes Therapeutics, For: Sep 23 Filed by: LANGE LOUIS G September 25, 2019 6:12 PM - SEC Filing Form SC 13G Audentes Therapeutics, Filed by: GREAT POINT PARTNERS LLC September 16, 2019 4:18 PM - SEC Filing Form 4 Audentes Therapeutics, For: Sep 05 Filed by: Soloway Thomas P September 9, 2019 4:07 PM - SEC Filing Form 4 Audentes Therapeutics, For: Sep 05 Filed by: Patterson Matthew R September 9, 2019 4:06 PM - SEC Filing Form 4 Audentes Therapeutics, For: Sep 05 Filed by: Holles Natalie C. September 9, 2019 4:05 PM - SEC Filing Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 6, 2019 6:00 PM - BizWire Audentes Therapeutics (BOLD) PT Raised to $50 at Chardan Capital Markets September 3, 2019 7:58 AM - StreetInsider Audentes Therapeutics to Participate in Upcoming Investor Conferences August 26, 2019 8:00 AM - PR NewsWire Form 8-K/A Audentes Therapeutics, For: Jun 07 August 23, 2019 4:03 PM - SEC Filing Form 4 Audentes Therapeutics, For: Aug 12 Filed by: Patterson Matthew R August 14, 2019 7:03 PM - SEC Filing Audentes Therapeutics (BOLD) PT Lowered to $30 at Citi August 7, 2019 6:35 AM - StreetInsider Form 10-Q Audentes Therapeutics, For: Jun 30 August 7, 2019 6:03 AM - SEC Filing Audentes Therapeutics (BOLD) Tops Q2 EPS by 3c August 6, 2019 4:53 PM - StreetInsider Form 8-K Audentes Therapeutics, For: Aug 06 August 6, 2019 4:08 PM - SEC Filing Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update August 6, 2019 4:01 PM - PR NewsWire Audentes Therapeutics to Participate in Upcoming Investor Conferences August 1, 2019 8:00 AM - PR NewsWire Audentes Therapeutics to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 6, 2019 July 30, 2019 8:00 AM - PR NewsWire Raymond James Resumes Audentes Therapeutics (BOLD) at Outperform July 29, 2019 6:58 AM - StreetInsider Full Article List